Choksey's view on Reliance Industries

Deven Choksey, MD, KR Choksey Securities share his view on Reliance Industries.

Choksey told CNBC-TV18, "From the frontliners Reliance is probably not getting as much affected due to all of this. Of course I think the controversies around and probably that is playing heavy on the minds of the investors. But at the same time I think this stock is having cash in the balance sheet of around Rs 250 at the end of this financial year. So I think that is relatively a safer kind of company as I would call it from the topline stocks."

He further added, "You may find some of the midcap companies which are looking quite interesting from investment point of view. You may find companies like IndusInd Bank, Glenmark Pharma which probably I think goes well at this point of time in the business."

"I think some of the infrastructure companies which are in the asset ownership space like Mundra Port. Some of these companies are not getting affected with the kind of a situation in which we are as much as I think the others are particularly on the mark to market provisioning side of forex. So these are the companies which we like from investment point of view. They are relatively safe compared to many other stocks into the market."